Calmark Sweden AB is a Sweden-based Company providing patient-near-term testing (PNA) specialized in newborns. Its main focus is to develop medical diagnostic biotechnology. The Company focuses on the development of solutions for point-of-care detection of critical illness. Calmark Sweden AB supports physicians and other healthcare professionals to detect illness independently of the cause and regardless of the symptoms.